PROK Long 5R

PROK Long 5R

5R trade on PROK

ProKidney Corp. (NASDAQ: PROK) is a clinical-stage biotechnology company focused on developing cell therapy solutions for chronic kidney disease (CKD). Its flagship product, REACT (Renal Autologous Cell Therapy), uses a patient’s own renal cells to restore kidney function and potentially halt CKD progression

Read More

Share:

Latest News